INPLASY202160033 Comparison of PARP Inhibitors as Maintenance Therapy for Platinum-Sensitive Recurrent Ovarian Cancer: A Network Meta-Analysis PARP inhibitor; ovarian cancer; maintenance therapy; network meta-analysis; progression-free survival; adverse reactions. Download PDF - 202160033 Review Status: Completed and published